News

These data indicate that, if clinically validated, VGX-100 has the potential to be a useful new treatment for some types of cancer. VGX-100 is a fully human monoclonal

The agreement provides Ivax Diagnostics the rights for Diamedix and Delta Biologicals subsidiaries to distribute Biomerica’s suite of products which includes 33 ELISA (Enzyme-Linked Immunosorbent Assay) test kits

Required for FDA new drug application (NDA) submission, this combination rule study – comparing the efficacy and safety profiles of MoxDuoIR against component doses of morphine and oxycodone

NiKem Research claimed that it has provided high quality cost-effective bioanalytical support both for its in-vitro ADME and in-vivo PK services associated to various drug discovery programs and

Pancreaze (pancrelipase) delayed-release capsules are indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Pancreaze is a combination of porcine-derived lipases, proteases,

Earlier, in March 2009, Aveo had entered into an exclusive option and license agreement with Biogen Idec International, a subsidiary of Biogen Idec, regarding the development and commercialisation

Ondansetron is the generic equivalent GlaxoSmithKline’s Zofran ODT. It is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic to treat nausea and vomiting, often following chemotherapy.

UCB claimed that the study of Rotigotine in patients with moderate to severe RLS was the longest ever open label prospective follow-up of a placebo-controlled phase II trial

Sloning BioTechnology said that Slonomics is a patented technology that uses a set of double stranded DNA triplets as universal building blocks for the synthesis of combinatorial libraries